4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Dr. Reddy's Laboratories Limited (RDY) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Hyderabad, India with about 27,527 employees. Its market capitalization is roughly $10 billion. In the fiscal year ended 2026-03-31, RDY reported $335.9B in revenue and $42.9B in net income.
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment.
Interactive charts & full statements → Open the RDY valuation workbench →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $335.9B | $325.5B | $279.2B | $245.9B | — |
| Gross Profit | $177.3B | $190.4B | $163.6B | $139.3B | — |
| Operating Income (EBIT) | $50.1B | $72.0B | $65.3B | $59.1B | — |
| Net Income | $42.9B | $56.5B | $55.7B | $45.1B | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $75.2B | $87.3B | $88.1B | $85.5B | $85.1B | — |
| Gross Profit | $43.0B | $46.8B | $48.1B | $48.6B | $56.6B | — |
| Operating Income (EBIT) | $829M | $14.3B | $17.9B | $16.8B | $16.2B | — |
| Net Income | $2.2B | $12.1B | $14.4B | $14.2B | $15.9B | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | ($6.7B) | ($6.7B) | ($6.6B) | ($5.0B) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Dividends Paid | $0M | $0M | ($6.7B) | $0M | $0M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | $579.3B | $493.0B | $387.5B | $321.9B | — |
| Total Liabilities | $198.9B | $155.8B | $107.0B | $90.9B | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive RDY viewer.
About TickerBase · Data methodology & sources